Specifically, survival analysis showed that higher CYP1A2 expression is significantly associated with better survival rates in non-smokers and women with early-stage bladder cancer, supported by p-values of less than 0.05. The gene discussed is CYP1A2; the disease is urinary bladder carcinoma.